Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Gastrointestinal Stromal Tumors 8 Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 2 Hematologic Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor Cancer 1 Rare Tumor 1 Rare Malignant Neoplasm 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Chronic-Phase 1 Digestive System Neoplasms 1 Congenital Bone Marrow Failure Syndromes 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Blast Crisis 1

Interventions

Sirolimus 1 Respiratory Function Tests 1 Phlebotomy 1 Imatinib Mesylate 1 Genetic Testing 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphangioleiomyomatosis × Imatinib Mesylate × Clear all

NCT06889168 2026-01-21

LAMP-2

Columbia University

Phase 1 Recruiting

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡